In this presentation, Dr. James Gasper, PharmD, BCPP, explores the impact of the evolving cannabis landscape in the U.S. Furthermore, Dr. Gasper reviews cannabis pharmacology and pharmacotherapy, and current recommendations… […]
Keyword: disorder
Co-Occurring Disorders | February 18, 2025
In this presentation, CDR Draude, PharmD, BCPP, AAHIVP, focuses on the comorbidity of mental health disorders and substance use disorders (SUDs), providing strategies for screening and treatment. Participants will learn… […]
Managing Alcohol Withdrawal in Ambulatory Care | January 21, 2025
In this presentation, Dr. James Gasper, PharmD, BCPP, provides a comprehensive overview on optimizing the management of alcohol withdrawal in ambulatory care settings, with an emphasis on identifying low to… […]
Read More… from Managing Alcohol Withdrawal in Ambulatory Care | January 21, 2025
Autism Spectrum Disorders | November 7, 2024
In this session, Dr. Carol Greenlee, endocrinologist, leads a discussion, providing recommendations, considerations, and supporting literature for an active patient case regarding autism spectrum disorders (ASD) and diabetes. […]
Read More… from Autism Spectrum Disorders | November 7, 2024
Bridging the Gap: Updates in Substance Use Treatment in the ED | June 12, 2024
In this presentation, Dr. Erik Anderson, MD, discusses discusses updates in treatment of alcohol use disorder and alcohol withdrawal in the ED, how to utilize novel strategies to start buprenorphine… […]
Read More… from Bridging the Gap: Updates in Substance Use Treatment in the ED | June 12, 2024
Managing Substance Use in the ED | June 12, 2024
In this presentation, Dr. Sarah Wakeman, MD, discusses updates in treatment of substance use disorders in the ED, reviews a buprenorphine quick start protocol in the ED, and describes and… […]
Read More… from Managing Substance Use in the ED | June 12, 2024
Buprenorphine Long-Acting Injectables | April 16, 2024
In this presentation, LCDR Draude, PharmD, describes the available buprenorphine Long-Acting Injectable (LAI) agents. LCDR Draude compares and contrasts the LAIs, including dosing and clinical considerations, and discusses the use… […]
Read More… from Buprenorphine Long-Acting Injectables | April 16, 2024
MOUD & Criminal Justice | February 20, 2024
In this presentation, Jeremy Hubbard, MS (Criminal Justice), describes the non-monetary positive impacts of Medication for Opioid Use Disorder (MOUD) on both community and incarcerated Justice Involved Adults in Jackson County… […]
Managing Methamphetamine Use in the ED | May 24, 2023
In this presentation, Dr. Erik Anderson, MD, describes the burden and complexity of clinical care in the ED related to methamphetamine use disorder. Furthermore, Dr. Anderson reviews strategies to manage complications,… […]
Read More… from Managing Methamphetamine Use in the ED | May 24, 2023
Outpatient Management of Stimulant Use Disorder & Cardiac Considerations | April 18, 2023
In this series of presentations, Dr. Phillip Coffin, Director of Substance Use Research, San Francisco Department of Public Health, provides an overview of outpatient management of stimulant use disorder. Dr.… […]











































